Unknown

Dataset Information

0

Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.


ABSTRACT: The idea that point mutations in exons may affect splicing is intriguing and adds an additional layer of complexity when evaluating their possible effects. Even in the best-studied examples, the molecular mechanisms are not fully understood. Here, we use patient cells, model minigenes, and in vitro assays to show that a missense mutation in exon 5 of the medium-chain acyl-CoA dehydrogenase (MCAD) gene primarily causes exon skipping by inactivating a crucial exonic splicing enhancer (ESE), thus leading to loss of a functional protein and to MCAD deficiency. This ESE functions by antagonizing a juxtaposed exonic splicing silencer (ESS) and is necessary to define a suboptimal 3' splice site. Remarkably, a synonymous polymorphic variation in MCAD exon 5 inactivates the ESS, and, although this has no effect on splicing by itself, it makes splicing immune to deleterious mutations in the ESE. Furthermore, the region of MCAD exon 5 that harbors these elements is nearly identical to the exon 7 region of the survival of motor neuron (SMN) genes that contains the deleterious silent mutation in SMN2, indicating a very similar and finely tuned interplay between regulatory elements in these two genes. Our findings illustrate a mechanism for dramatic context-dependent effects of single-nucleotide polymorphisms on gene-expression regulation and show that it is essential that potential deleterious effects of mutations on splicing be evaluated in the context of the relevant haplotype.

SUBMITTER: Nielsen KB 

PROVIDER: S-EPMC1821120 | biostudies-literature | 2007 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.

Nielsen Karsten Bork KB   Sørensen Suzette S   Cartegni Luca L   Corydon Thomas Juhl TJ   Doktor Thomas Koed TK   Schroeder Lisbeth Dahl LD   Reinert Line Sinnathamby LS   Elpeleg Orly O   Krainer Adrian R AR   Gregersen Niels N   Kjems Jørgen J   Andresen Brage Storstein BS  

American journal of human genetics 20070118 3


The idea that point mutations in exons may affect splicing is intriguing and adds an additional layer of complexity when evaluating their possible effects. Even in the best-studied examples, the molecular mechanisms are not fully understood. Here, we use patient cells, model minigenes, and in vitro assays to show that a missense mutation in exon 5 of the medium-chain acyl-CoA dehydrogenase (MCAD) gene primarily causes exon skipping by inactivating a crucial exonic splicing enhancer (ESE), thus l  ...[more]

Similar Datasets

| S-EPMC2741454 | biostudies-literature
| S-EPMC3732970 | biostudies-literature
| S-EPMC4537296 | biostudies-literature
| S-EPMC9737616 | biostudies-literature
| S-EPMC1180494 | biostudies-literature
| S-EPMC6325764 | biostudies-literature
| S-EPMC5793168 | biostudies-literature
| S-EPMC6169883 | biostudies-literature
| S-EPMC1088389 | biostudies-literature
| S-EPMC1182240 | biostudies-literature